741 related articles for article (PubMed ID: 34816624)
21. Prevalence of muscle dysfunction concomitant with osteoporosis in a home-dwelling Danish population aged 65-93 years - The Copenhagen Sarcopenia Study.
Nielsen BR; Andersen HE; Haddock B; Hovind P; Schwarz P; Suetta C
Exp Gerontol; 2020 Sep; 138():110974. PubMed ID: 32464171
[TBL] [Abstract][Full Text] [Related]
22. Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.
Tessier AJ; Wing SS; Rahme E; Morais JA; Chevalier S
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):985-999. PubMed ID: 31307126
[TBL] [Abstract][Full Text] [Related]
23. Identifying Sarcopenia in Female Long-Term Care Residents: A Comparison of Current Guidelines.
Kotlarczyk MP; Perera S; Nace DA; Resnick NM; Greenspan SL
J Am Geriatr Soc; 2018 Feb; 66(2):316-320. PubMed ID: 29155456
[TBL] [Abstract][Full Text] [Related]
24. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus.
de Freitas MM; de Oliveira VLP; Grassi T; Valduga K; Miller MEP; Schuchmann RA; Souza KLA; de Azevedo MJ; Viana LV; de Paula TP
Exp Gerontol; 2020 Apr; 132():110835. PubMed ID: 31954325
[TBL] [Abstract][Full Text] [Related]
25. Urban-rural differences in the prevalence and associated factors of sarcopenia: A systematic review and meta-analysis.
Li X; Wang R; Hou Z; Sun Q
Arch Gerontol Geriatr; 2024 Jul; 122():105390. PubMed ID: 38460267
[TBL] [Abstract][Full Text] [Related]
26. Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort - a comparison to the EWGSOP2 cut-off points.
Huemer MT; Kluttig A; Fischer B; Ahrens W; Castell S; Ebert N; Gastell S; Jöckel KH; Kaaks R; Karch A; Keil T; Kemmling Y; Krist L; Leitzmann M; Lieb W; Meinke-Franze C; Michels KB; Mikolajczyk R; Moreno Velásquez I; Pischon T; Schipf S; Schmidt B; Schöttker B; Schulze MB; Stocker H; Teismann H; Wirkner K; Drey M; Peters A; Thorand B
Age Ageing; 2023 Jan; 52(1):. PubMed ID: 36702514
[TBL] [Abstract][Full Text] [Related]
27. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients.
Reiss J; Iglseder B; Alzner R; Mayr-Pirker B; Pirich C; Kässmann H; Kreutzer M; Dovjak P; Reiter R
Age Ageing; 2019 Sep; 48(5):719-724. PubMed ID: 31112221
[TBL] [Abstract][Full Text] [Related]
28. Sarcopenia and its components in adult renal transplant recipients: prevalence and association with body adiposity.
Menna Barreto APM; Barreto Silva MI; Pontes KSDS; Costa MSD; Rosina KTC; Souza E; Bregman R; Klein MRST
Br J Nutr; 2019 Dec; 122(12):1386-1397. PubMed ID: 31551095
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies.
Shafiee G; Keshtkar A; Soltani A; Ahadi Z; Larijani B; Heshmat R
J Diabetes Metab Disord; 2017; 16():21. PubMed ID: 28523252
[TBL] [Abstract][Full Text] [Related]
30. Performance of the EWGSOP2 Cut-Points of Low Grip Strength for Identifying Sarcopenia and Frailty Phenotype: A Cross-Sectional Study in Older Inpatients.
Stuck AK; Mäder NC; Bertschi D; Limacher A; Kressig RW
Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33800552
[TBL] [Abstract][Full Text] [Related]
31. Which is the best alternative to estimate muscle mass for sarcopenia diagnosis when DXA is unavailable?
Sousa-Santos AR; Barros D; Montanha TL; Carvalho J; Amaral TF
Arch Gerontol Geriatr; 2021; 97():104517. PubMed ID: 34547538
[TBL] [Abstract][Full Text] [Related]
32. How do we define and measure sarcopenia? A meta-analysis of observational studies.
Carvalho do Nascimento PR; Bilodeau M; Poitras S
Age Ageing; 2021 Nov; 50(6):1906-1913. PubMed ID: 34537833
[TBL] [Abstract][Full Text] [Related]
33. Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual X-ray absorptiometry.
Reiss J; Iglseder B; Kreutzer M; Weilbuchner I; Treschnitzer W; Kässmann H; Pirich C; Reiter R
BMC Geriatr; 2016 Feb; 16():52. PubMed ID: 26928275
[TBL] [Abstract][Full Text] [Related]
34. Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis.
Papadopoulou SK; Tsintavis P; Potsaki P; Papandreou D
J Nutr Health Aging; 2020; 24(1):83-90. PubMed ID: 31886813
[TBL] [Abstract][Full Text] [Related]
35. Utility of four sarcopenia criteria for the prediction of falls-related hospitalization in older Australian women.
Sim M; Prince RL; Scott D; Daly RM; Duque G; Inderjeeth CA; Zhu K; Woodman RJ; Hodgson JM; Lewis JR
Osteoporos Int; 2019 Jan; 30(1):167-176. PubMed ID: 30456572
[TBL] [Abstract][Full Text] [Related]
36. The Need for a New Cut-off Value to Increase Diagnostic Performance of Bioelectrical Impedance Analysis Compared with Dual-Energy X-ray Absorptiometry to Measure Muscle Mass in Indonesian Elderly.
Laksmi PW; Sukma FA; Setyohadi B; Nugroho P; Ariane A; Tirtarahardja G
Acta Med Indones; 2019 Apr; 51(2):95-101. PubMed ID: 31383823
[TBL] [Abstract][Full Text] [Related]
37. Sarcopenia diagnosis in patients receiving hemodialysis: Agreement among different consensuses.
Rosa CSC; Ribeiro HS; Vogt BP; Sakkas GK; Monteiro HL
Nutr Clin Pract; 2022 Dec; 37(6):1348-1355. PubMed ID: 34970778
[TBL] [Abstract][Full Text] [Related]
38. Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults.
Kim H; Hirano H; Edahiro A; Ohara Y; Watanabe Y; Kojima N; Kim M; Hosoi E; Yoshida Y; Yoshida H; Shinkai S
Geriatr Gerontol Int; 2016 Mar; 16 Suppl 1():110-22. PubMed ID: 27018289
[TBL] [Abstract][Full Text] [Related]
39. Methods, diagnostic criteria, cutoff points, and prevalence of sarcopenia among older people.
Pagotto V; Silveira EA
ScientificWorldJournal; 2014; 2014():231312. PubMed ID: 25580454
[TBL] [Abstract][Full Text] [Related]
40. Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program.
Shafiee G; Heshmat R; Ostovar A; Khatami F; Fahimfar N; Arzaghi SM; Gharibzadeh S; Hanaei S; Nabipour I; Larijani B
J Diabetes Metab Disord; 2020 Dec; 19(2):727-734. PubMed ID: 33520799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
